K221641 is an FDA 510(k) clearance for the Terragene® Bionova® Hyper Biological Indicator (BT98), Terragene® Bionova® Hyper Auto-reader Incubator (BHY), Terragene® Bionova® NanoBio Auto-reader Incubator (BNB). This device is classified as a Indicator, Biological Sterilization Process (Class II - Special Controls, product code FRC).
Submitted by Terragene S.A. (Alvear, AR). The FDA issued a Cleared decision on February 28, 2023, 267 days after receiving the submission on June 6, 2022.
This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.2800.